[{"address1": "41 South Rio Grande Street", "city": "Salt Lake City", "state": "UT", "zip": "84101", "country": "United States", "phone": "385 269 0203", "fax": "801 821 2872", "website": "https://www.recursion.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.", "fullTimeEmployees": 500, "auditRisk": 3, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 8, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 2, "previousClose": 9.15, "open": 9.1, "dayLow": 8.62, "dayHigh": 9.22, "regularMarketPreviousClose": 9.15, "regularMarketOpen": 9.1, "regularMarketDayLow": 8.62, "regularMarketDayHigh": 9.22, "beta": 0.858, "forwardPE": -4.7326207, "volume": 8714510, "regularMarketVolume": 8714510, "averageVolume": 4652096, "averageVolume10days": 4261190, "averageDailyVolume10Day": 4261190, "bid": 8.78, "ask": 8.91, "bidSize": 700, "askSize": 1300, "marketCap": 2103326464, "fiftyTwoWeekLow": 4.97, "fiftyTwoWeekHigh": 16.745, "priceToSalesTrailing12Months": 45.492085, "fiftyDayAverage": 8.7114, "twoHundredDayAverage": 8.916075, "currency": "USD", "enterpriseValue": 1857978112, "floatShares": 191916394, "sharesOutstanding": 230274000, "sharesShort": 42368012, "sharesShortPriorMonth": 38704268, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.1783, "heldPercentInsiders": 0.05199, "heldPercentInstitutions": 0.97213, "shortRatio": 8.27, "shortPercentOfFloat": 0.2688, "impliedSharesOutstanding": 252224992, "bookValue": 1.689, "priceToBook": 5.239787, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -354112000, "trailingEps": -1.63, "forwardEps": -1.87, "pegRatio": -0.46, "enterpriseToRevenue": 40.186, "enterpriseToEbitda": -5.315, "52WeekChange": 0.21067035, "SandP52WeekChange": 0.26238096, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "RXRX", "underlyingSymbol": "RXRX", "shortName": "Recursion Pharmaceuticals, Inc.", "longName": "Recursion Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1618579800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "b61b6c65-adf4-3158-aa09-6b9439d85de8", "messageBoardId": "finmb_261401243", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.85, "targetHighPrice": 17.0, "targetLowPrice": 10.0, "targetMeanPrice": 13.0, "targetMedianPrice": 12.5, "recommendationMean": 2.7, "recommendationKey": "hold", "numberOfAnalystOpinions": 6, "totalCash": 296326016, "totalCashPerShare": 1.247, "ebitda": -349544992, "totalDebt": 50974000, "quickRatio": 4.044, "currentRatio": 4.648, "totalRevenue": 46235000, "debtToEquity": 12.707, "revenuePerShare": 0.211, "returnOnAssets": -0.39824, "returnOnEquity": -0.85192, "freeCashflow": -208611744, "operatingCashflow": -316764000, "revenueGrowth": 0.137, "grossMargins": -0.34504002, "operatingMargins": -6.9763703, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]